Inovio Pharmaceuticals
INO
#9486
Rank
C$0.18 B
Marketcap
C$1.79
Share price
2.38%
Change (1 day)
-46.93%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2026 (TTM): -C$0.13 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$0.13 Billion, an increase over its 2024 earnings that were of -C$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.13 Billion-3.84%
2025 -C$0.13 Billion-15.67%
2024 -C$0.15 Billion-20.03%
2023 -C$0.19 Billion-51.56%
2022 -C$0.39 Billion-8.26%
2021 -C$0.42 Billion95.4%
2020 -C$0.22 Billion36.62%
2019 -C$0.16 Billion20.19%
2018 -C$0.14 Billion10.94%
2017 -C$0.12 Billion9.59%
2016 -C$0.11 Billion118.9%
2015 -C$49.05 Million-10.67%
2014 -C$54.91 Million83.32%
2013 -C$29.95 Million
2011 -C$30.9 Million15.64%
2010 -C$26.72 Million37.7%
2009 -C$19.41 Million2.19%
2008 -C$18.99 Million-14.09%
2007 -C$22.11 Million19.12%
2006 -C$18.56 Million9.62%
2005 -C$16.93 Million5.77%
2004 -C$16.01 Million73.08%
2003 -C$9.25 Million12.75%
2002 -C$8.2 Million
2000 -C$12.42 Million53.93%
1999 -C$8.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.11 B-29,892.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$21.94 B-18,200.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$14.72 B-12,245.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$14.91 B-12,402.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.28 B-15,182.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$13.91 B-11,580.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-C$3.83 Million-96.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-C$0.23 Billion 83.29%๐Ÿ‡บ๐Ÿ‡ธ USA